These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7874526)

  • 21. Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow.
    Fatini C; Sticchi E; Gensini F; Genuardi M; Tondi F; Gensini GF; Riviello C; Parretti E; Mello G; Abbate R
    J Hypertens; 2006 Sep; 24(9):1823-9. PubMed ID: 16915032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
    Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Random urine protein to creatinine ratio as a diagnostic method of significant proteinuria in pre-eclampsia.
    Zadehmodarres S; Razzaghi MR; Habibi G; Najmi Z; Jam H; Mosaffa N; Kaboosi M
    Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):501-4. PubMed ID: 17116054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservative management of eclampsia and severe pre-eclampsia--A Bangladesh experience.
    Begum MR; Akhter S; Begum A; Khatun M; Quadir E; Choudhury SB
    Medscape Womens Health; 2002 Jan; 7(1):1. PubMed ID: 11965219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia.
    Qublan HS; Ammarin V; Bataineh O; Al-Shraideh Z; Tahat Y; Awamleh I; Khreisat B; Nussair B; Amarin ZO
    Med Sci Monit; 2005 Aug; 11(8):CR393-7. PubMed ID: 16049382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100B protein expression in the amnion and amniotic fluid in pregnancies complicated by pre-eclampsia.
    Tskitishvili E; Komoto Y; Temma-Asano K; Hayashi S; Kinugasa Y; Tsubouchi H; Song M; Kanagawa T; Shimoya K; Murata Y
    Mol Hum Reprod; 2006 Dec; 12(12):755-61. PubMed ID: 17023485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines for the management of hypertensive disorders of pregnancy 2008.
    Lowe SA; Brown MA; Dekker GA; Gatt S; McLintock CK; McMahon LP; Mangos G; Moore MP; Muller P; Paech M; Walters B;
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):242-6. PubMed ID: 19566552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsia.
    Cotter AM; Martin CM; O'Leary JJ; Daly SF
    BJOG; 2005 May; 112(5):584-7. PubMed ID: 15842281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Measurement of blood pressure in pregnancy].
    Henriksen T
    Tidsskr Nor Laegeforen; 1998 Feb; 118(5):735-7. PubMed ID: 9528371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension in pregnancy.
    Meher S; Neilson J
    Practitioner; 2004 Oct; 248(1663):720, 722, 724 passim. PubMed ID: 15491015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HELLP: a collaborative challenge for critical care and obstetric nurses.
    Koenigseder LA; Crane PB; Lucy PW
    Am J Crit Care; 1993 Sep; 2(5):385-92; quiz 393-4. PubMed ID: 8220670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure and urinalysis are often omitted in women who have suffered pre-eclampsia at their six-week postnatal check.
    Samwiil L; Mercer C; Jarrett P; O'Malley S;
    BJOG; 2004 Jun; 111(6):623-5. PubMed ID: 15198793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.
    Crowley A; Martin C; Fitzpatrick P; Sheils O; O'Herlihy C; O'Leary JJ; Byrne BM
    Prenat Diagn; 2007 Feb; 27(2):174-9. PubMed ID: 17191257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STOX1 gene in pre-eclampsia and intrauterine growth restriction.
    Berends AL; Bertoli-Avella AM; de Groot CJ; van Duijn CM; Oostra BA; Steegers EA
    BJOG; 2007 Sep; 114(9):1163-7. PubMed ID: 17617193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myometrial and placental artery reactivity alone cannot explain reduced placental perfusion in pre-eclampsia and intrauterine growth restriction.
    Ong SS; Moore RJ; Warren AY; Crocker IP; Fulford J; Tyler DJ; Gowland PA; Baker PN
    BJOG; 2003 Oct; 110(10):909-15. PubMed ID: 14550360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reflexions about midwives' knowledge and management of pre-eclampsia.
    Dalfó Pibernat A; García Millán R; Dalfó Pibernat E
    J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102160. PubMed ID: 33962050
    [No Abstract]   [Full Text] [Related]  

  • 37. Nurse-midwifery management of preeclampsia. Two case studies.
    Kelley M
    J Nurse Midwifery; 1985; 30(2):105-11. PubMed ID: 3850940
    [No Abstract]   [Full Text] [Related]  

  • 38. What happens when the midwife is ignored?
    Dimond B
    Mod Midwife; 1995 Jun; 5(6):32-3. PubMed ID: 7788404
    [No Abstract]   [Full Text] [Related]  

  • 39. [Perinatal nursing care of patients with pregnancy toxemias].
    Nomura N
    Josanpu Zasshi; 1984 Aug; 38(8):665-71. PubMed ID: 6565797
    [No Abstract]   [Full Text] [Related]  

  • 40. [Care of a pre-eclampsia multipara with repeated pregnancy loss].
    Chou CH
    Hu Li Za Zhi; 1981 Jul; 28(3):11-6. PubMed ID: 6914355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.